Search

Search Constraints

You searched for: Author/Creator Tay, Wan Ting

Search Results

1. A comprehensive population‐based characterization of heart failure with mid‐range ejection fraction. (25th September 2017)

2. Association between body surface area and prescribed doses of guideline‐directed medications among international patients with heart failure and reduced ejection fraction. (18th December 2019)

3. Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection Fraction. Issue 17 (September 2019)

4. Chronic obstructive pulmonary disease and β‐blocker treatment in Asian patients with heart failure. (21st October 2017)

5. Correction to: Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study. Issue 8 (August 2020)

7. Disparity Between Indications for and Utilization of Implantable Cardioverter Defibrillators in Asian Patients With Heart Failure. Issue 11 (November 2017)

8. Effects of combined renin–angiotensin–aldosterone system inhibitor and beta‐blocker treatment on outcomes in heart failure with reduced ejection fraction: insights from BIOSTAT‐CHF and ASIAN‐HF registries. (25th June 2020)

9. Epicardial adipose tissue related to left atrial and ventricular function in heart failure with preserved versus reduced and mildly reduced ejection fraction. (26th June 2022)

10. Epicardial fat in heart failure with reduced versus preserved ejection fraction. (30th March 2021)